Volke V - Search Results

1

GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.

Krass M, Volke A, Rünkorg K, Wegener G, Lund S, Abildgaard A, Vasar E, Volke V. Krass M, et al. Among authors: volke a, volke v. Acta Neuropsychiatr. 2015 Feb;27(1):25-32. doi: 10.1017/neu.2014.36. Epub 2014 Dec 3. Acta Neuropsychiatr. 2015. PMID: 25469828

2

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.

Volke V, Kõks S, Vasar E, Bourin M, Bradwejn J, Männistö PT. Volke V, et al. Neuroreport. 1995 Jul 10;6(10):1413-6. doi: 10.1097/00001756-199507100-00013. Neuroreport. 1995. PMID: 7488737

3

Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.

Lang A, Harro J, Soosaar A, Kõks S, Volke V, Oreland L, Bourin M, Vasar E, Bradwejn J, Männistö PT. Lang A, et al. Among authors: volke v. Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):363-70. doi: 10.1007/BF00169076. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 7630427

4

Pharmacological comparison of antipsychotic drugs and sigma-antagonists in rodents.

Lang A, Soosaar A, Kõks S, Volke V, Bourin M, Bradwejn J, Vasar E. Lang A, et al. Among authors: volke v. Pharmacol Toxicol. 1994 Sep-Oct;75(3-4):222-7. doi: 10.1111/j.1600-0773.1994.tb00351.x. Pharmacol Toxicol. 1994. PMID: 7800667

5

Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze.

Vasar E, Lang A, Harro J, Kõks S, Volke V, Sihver S, Bourin M, Bradwejn J, Männistö PT. Vasar E, et al. Among authors: volke v. Neuropeptides. 1994 Jan;26(1):39-45. doi: 10.1016/0143-4179(94)90091-4. Neuropeptides. 1994. PMID: 8159285

6

Anti-exploratory effect of N-methyl-D-aspartate in elevated plus-maze. Involvement of NMDA and CCK receptors.

Vasar E, Harro J, Lang A, Soosaar A, Oöpik T, Kôks S, Sihver S, Volke V. Vasar E, et al. Among authors: volke v. Eur Neuropsychopharmacol. 1993 Mar;3(1):63-73. doi: 10.1016/0924-977x(93)90296-x. Eur Neuropsychopharmacol. 1993. PMID: 8471831

7

Nitric oxide mediates caerulein-induced suppression of locomotor activity.

Volke V, Soosaar A, Kõks S, Bourin M, Männistö PT, Vasar E. Volke V, et al. Neuropeptides. 1996 Aug;30(4):323-6. doi: 10.1016/s0143-4179(96)90020-7. Neuropeptides. 1996. PMID: 8914857

8

7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety.

Volke V, Soosaar A, Kõks S, Bourin M, Männistö PT, Vasar E. Volke V, et al. Psychopharmacology (Berl). 1997 Jun;131(4):399-405. doi: 10.1007/s002130050309. Psychopharmacology (Berl). 1997. PMID: 9226743

9

Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levels.

Kõks S, Vasar E, Soosaar A, Lang A, Volke V, Võikar V, Bourin M, Männistö PT. Kõks S, et al. Among authors: volke v. Eur Neuropsychopharmacol. 1997 Nov;7(4):289-94. doi: 10.1016/s0924-977x(97)00034-5. Eur Neuropsychopharmacol. 1997. PMID: 9443661

10

L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats.

Volke V, Soosaar A, Kõks S, Vasar E, Männistö PT. Volke V, et al. Eur J Pharmacol. 1998 Jun 26;351(3):287-90. doi: 10.1016/s0014-2999(98)00364-1. Eur J Pharmacol. 1998. PMID: 9721019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters